Induction Chemotherapy of Docetaxel, Cisplatin and Xeloda in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Latest Information Update: 04 Aug 2021
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 16 Jun 2016 New trial record